<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Bang CS</submitter><pubmed_abstract>&lt;b>Background/Aims:&lt;/b> Although acid suppressants are widely used for the prevention or treatment of drug-induced upper gastrointestinal bleeding (GIB), evidence regarding the prevention of anticoagulant-related GIB is scarce. The aim of this study was to evaluate the protective effect of acid suppressants against anticoagulant-related GIB. &lt;b>Methods:&lt;/b> A systematic review was conducted of studies that evaluated the protective effect of acid suppressants against anticoagulant-related GIB found in PubMed, the Cochrane library, Embase, and KoreaMed from the date of database inception to April 2018. Random effect model meta-analyses with sensitivity analyses were conducted. The methodological quality of each included publication was evaluated using the Risk of Bias Assessment Tool for Nonrandomized Studies. Publication bias was assessed. &lt;b>Results:&lt;/b> In total, six nested case-control or cohort studies were identified and analyzed. Proton-pump inhibitors (PPI) had a protective effect against upper GIB in patients on dicumarinics (risk ratio [RR], 0.56; 95% confidence interval [CI], 0.38 to 0.83; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 0%); however, the histamine-2 receptor antagonist did not have the same effect (RR, 0.97; 95% CI, 0.52 to 1.81; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 0%). Acid suppressants did not have a protective effect against GIB in patients on dabigatran (hazard ratio, 0.78; 95% CI, 0.44 to 1.37; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 81.8%). &lt;b>Conclusions:&lt;/b> The protective effect of PPIs against dicumarinics-related upper GIB was clear, while there was no evidence supporting the protective effect of acid suppressants against dabigatran-related GIB. However, in the absence of randomized trials demonstrating a lack of bias, solid conclusions cannot be drawn.</pubmed_abstract><journal>Gut and liver</journal><pagination>57-66</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6974330</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Role of Acid Suppressants in the Prevention of Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC6974330</pmcid><pubmed_authors>Joo MK</pubmed_authors><pubmed_authors>Bang CS</pubmed_authors><pubmed_authors>Cho YK</pubmed_authors><pubmed_authors>Park JM</pubmed_authors><pubmed_authors>Park CH</pubmed_authors><pubmed_authors>Kim BJ</pubmed_authors><pubmed_authors>Jung HK</pubmed_authors><pubmed_authors>Kim JS</pubmed_authors><pubmed_authors>Yang HJ</pubmed_authors><pubmed_authors>Kim BW</pubmed_authors><pubmed_authors>Lee BE</pubmed_authors><pubmed_authors>Korean College of Helicobacter and Upper Gastrointestinal Research</pubmed_authors><pubmed_authors>Ahn JY</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Role of Acid Suppressants in the Prevention of Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.</name><description>&lt;b>Background/Aims:&lt;/b> Although acid suppressants are widely used for the prevention or treatment of drug-induced upper gastrointestinal bleeding (GIB), evidence regarding the prevention of anticoagulant-related GIB is scarce. The aim of this study was to evaluate the protective effect of acid suppressants against anticoagulant-related GIB. &lt;b>Methods:&lt;/b> A systematic review was conducted of studies that evaluated the protective effect of acid suppressants against anticoagulant-related GIB found in PubMed, the Cochrane library, Embase, and KoreaMed from the date of database inception to April 2018. Random effect model meta-analyses with sensitivity analyses were conducted. The methodological quality of each included publication was evaluated using the Risk of Bias Assessment Tool for Nonrandomized Studies. Publication bias was assessed. &lt;b>Results:&lt;/b> In total, six nested case-control or cohort studies were identified and analyzed. Proton-pump inhibitors (PPI) had a protective effect against upper GIB in patients on dicumarinics (risk ratio [RR], 0.56; 95% confidence interval [CI], 0.38 to 0.83; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 0%); however, the histamine-2 receptor antagonist did not have the same effect (RR, 0.97; 95% CI, 0.52 to 1.81; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 0%). Acid suppressants did not have a protective effect against GIB in patients on dabigatran (hazard ratio, 0.78; 95% CI, 0.44 to 1.37; &lt;i>I&lt;sup>2&lt;/sup>&lt;/i>, 81.8%). &lt;b>Conclusions:&lt;/b> The protective effect of PPIs against dicumarinics-related upper GIB was clear, while there was no evidence supporting the protective effect of acid suppressants against dabigatran-related GIB. However, in the absence of randomized trials demonstrating a lack of bias, solid conclusions cannot be drawn.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2021-02-21T00:44:55Z</modification><creation>2020-05-22T09:21:17Z</creation></dates><accession>S-EPMC6974330</accession><cross_references><pubmed>30974930</pubmed><doi>10.5009/gnl19009</doi></cross_references></HashMap>